Accelerating Biomarker-driven Patient Outcomes
Time: 9:25 am
day: Day Two AM
Details:
- Rapid advances in early detection, monitoring, personalized medicine and RWE can transform medical innovation and patient outcomes
- Arguably, however, CDx and Dx reimbursement models do little to reinforce translation into speed and outcomes, particularly in Europe
- What alternative models are possible and emerging that could impact patients globally?
